Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
This study determined the percentage of children and adult samples from the St. Louis metropolitan area in Missouri with SARS-CoV-2 antibodies during three collection periods spanning April 2020 to January 2021. By January 2021, 20.68% of the tested individuals had antibodies. These results show th...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2021-08-01
|
Series: | mSphere |
Online Access: | https://journals.asm.org/doi/10.1128/mSphere.00450-21 |
id |
doaj-03493d85b1f24ed48508e23aff4fec42 |
---|---|
record_format |
Article |
spelling |
doaj-03493d85b1f24ed48508e23aff4fec422021-09-21T19:41:35ZengAmerican Society for MicrobiologymSphere2379-50422021-08-016410.1128/mSphere.00450-21Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021Brittany K. Smith0Andrew B. Janowski1https://orcid.org/0000-0003-4382-1194Arim C. Fremont2Lucas J. Adams3Ya-Nan Dai4Christopher W. Farnsworth5https://orcid.org/0000-0001-7169-3850Ann M. Gronowski6Stephen M. Roper7David Wang8https://orcid.org/0000-0002-0827-196XDaved H. Fremont9https://orcid.org/0000-0002-8544-2689Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA This study determined the percentage of children and adult samples from the St. Louis metropolitan area in Missouri with SARS-CoV-2 antibodies during three collection periods spanning April 2020 to January 2021. By January 2021, 20.68% of the tested individuals had antibodies. These results show the evolution of the SARS-CoV-2 pandemic in St. Louis, Missouri, and provide a snapshot of the extent of infection just prior to the start of mass vaccination.https://journals.asm.org/doi/10.1128/mSphere.00450-21 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Brittany K. Smith Andrew B. Janowski Arim C. Fremont Lucas J. Adams Ya-Nan Dai Christopher W. Farnsworth Ann M. Gronowski Stephen M. Roper David Wang Daved H. Fremont |
spellingShingle |
Brittany K. Smith Andrew B. Janowski Arim C. Fremont Lucas J. Adams Ya-Nan Dai Christopher W. Farnsworth Ann M. Gronowski Stephen M. Roper David Wang Daved H. Fremont Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021 mSphere |
author_facet |
Brittany K. Smith Andrew B. Janowski Arim C. Fremont Lucas J. Adams Ya-Nan Dai Christopher W. Farnsworth Ann M. Gronowski Stephen M. Roper David Wang Daved H. Fremont |
author_sort |
Brittany K. Smith |
title |
Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021 |
title_short |
Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021 |
title_full |
Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021 |
title_fullStr |
Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021 |
title_full_unstemmed |
Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021 |
title_sort |
progression of sars-cov-2 seroprevalence in st. louis, missouri, through january 2021 |
publisher |
American Society for Microbiology |
series |
mSphere |
issn |
2379-5042 |
publishDate |
2021-08-01 |
description |
This study determined the percentage of children and adult samples from the St. Louis metropolitan area in Missouri with SARS-CoV-2 antibodies during three collection periods spanning April 2020 to January 2021. By January 2021, 20.68% of the tested individuals had antibodies. These results show the evolution of the SARS-CoV-2 pandemic in St. Louis, Missouri, and provide a snapshot of the extent of infection just prior to the start of mass vaccination. |
url |
https://journals.asm.org/doi/10.1128/mSphere.00450-21 |
work_keys_str_mv |
AT brittanyksmith progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT andrewbjanowski progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT arimcfremont progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT lucasjadams progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT yanandai progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT christopherwfarnsworth progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT annmgronowski progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT stephenmroper progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT davidwang progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT davedhfremont progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 |
_version_ |
1717372150206169088 |